This inventor holds 4 USPTO granted patents and 3 published patent applications and 6 EPO patents. Top assignees: Glaxosmithkline Intellectual Property Development Limited, Glaxo Group Limited, Glaxogrouplimited. Active years: 2012-2014.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
2 out of 242 
1 out of 1,169 
1 out of 8 Years Active: 2012-2014
Title: The Innovative Contributions of Paul Faulder
Introduction
Paul Faulder is a notable inventor based in Stevenage, GB, recognized for his significant contributions to the field of pharmaceutical compounds. With a total of four patents to his name, Faulder has made strides in developing inhibitors of PI3-kinase activity, which are crucial in various therapeutic applications.
Latest Patents
Faulder's latest patents include innovative compounds directed towards inhibiting PI3-kinase activity. One of his inventions focuses on compounds of formula (I) and their salts, showcasing their potential as effective inhibitors. Another patent involves benzpyrazol derivatives, which are also designed to inhibit PI3-kinase activity, further emphasizing his commitment to advancing medical science through his research.
Career Highlights
Throughout his career, Faulder has worked with prominent organizations, including GlaxoSmithKline Intellectual Property Development Limited and Glaxo Group Limited. His experience in these companies has allowed him to contribute to significant advancements in pharmaceutical research and development.
Collaborations
Faulder has collaborated with esteemed colleagues such as Ian Robert Baldwin and Kenneth David Down, enhancing the scope and impact of his work in the field.
Conclusion
Paul Faulder's innovative work in developing PI3-kinase inhibitors highlights his valuable contributions to pharmaceutical science. His patents and collaborations reflect a dedication to advancing medical research and improving therapeutic options.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile